Clinical Trial Update: A Study of Memantine Hydrochloride (Namenda®) for Cognitive and Behavioral Impairment in Adults With Autism Spectrum Disorders [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating memantine hydrochloride (Namenda) for cognitive and behavioral impairment in adults with autism spectrum disorders has completed; resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autism Spectrum Disorders

Drugs mentioned

• Namenda (memantine)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Autism Spectrum Disorders | Phase 4 | Status: COMPLETED | Results posted: 2014-10-06